NCT04681313

Brief Summary

This study will examine the physiologic effects on loading conditions and contractility of the left ventricle during high-risk primary coronary intervention (HRPCI) in the Cardiac Cath Lab. This will be performed through analysis of real-time left ventricular (LV) pressure-volume loops (PVL) by continuously recording PVL during HRPCI with the Inca® Pressure-Volume Loop System that will be temporarily placed in the left ventricle during the procedure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 18, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 23, 2020

Completed
4 months until next milestone

Study Start

First participant enrolled

April 19, 2021

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
1.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 12, 2024

Completed
Last Updated

November 14, 2024

Status Verified

November 1, 2024

Enrollment Period

1.6 years

First QC Date

December 18, 2020

Last Update Submit

November 12, 2024

Conditions

Keywords

High Risk Percutaneous Coronary InterventionPressure-Volume Loop

Outcome Measures

Primary Outcomes (3)

  • Changes in left ventricular end diastolic pressure (LVEDP).

    Measured changes in left ventricular end diastolic pressure (LVEDP) as measured real-time by the Inca PV-Loop system.

    Immediate (during PCI).

  • Changes in left ventricular end systolic pressure.

    Measured changes in left ventricular end systolic pressure as measured real-time by the Inca PV-Loop system.

    Immediate (during PCI).

  • Changes in left ventricular compliance.

    Measured changes in left ventricular compliance as measured real-time by the Inca PV-Loop system.

    Immediate (during PCI).

Interventions

Percutaneous coronary interventions (PCI) deemed high risk based on patient-related risk features, hemodynamic criteria, clinical presentation and complexity of coronary anatomy.

Also known as: HRPCI

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Ten adult patients with planned elective HRPCI procedures. Procedures are deemed high-risk based on patient-related risk features, hemodynamic criteria, clinical presentation and complexity of coronary anatomy. Patient-related high risk features include low left ventricle ejection fraction (LVEF), advanced age, and comorbidities including advanced kidney disease, peripheral and cerebral vascular disease. High-risk baseline hemodynamic features include hypotension, severely elevated LVEDP, and severely depressed cardiac output. Coronary anatomy complexity criteria include left main coronary artery involvement, multi- vessel CAD, and severely calcified coronary lesions requiring atherectomy. The decision to use an MCS device for hemodynamic support will be planned, not randomized, as it will be made prior to patient enrollment based on the clinical judgment of the treating physician.

You may qualify if:

  • Adult patients (18 years and older) with known coronary artery disease and planned elective HRPCI procedures.

You may not qualify if:

  • Any patient not considered appropriate for elective HRPCI procedures.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Henry Ford Hospital

Detroit, Michigan, 48202, United States

Location

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • William O'Neill, MD

    Henry Ford Health System

    PRINCIPAL INVESTIGATOR
  • Mohammad Alqarqaz, MD

    Henry Ford Health System

    STUDY DIRECTOR
  • Mir Babar Basir, DO

    Henry Ford Health System

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, Center for Structural Heart Disease

Study Record Dates

First Submitted

December 18, 2020

First Posted

December 23, 2020

Study Start

April 19, 2021

Primary Completion

December 1, 2022

Study Completion

September 12, 2024

Last Updated

November 14, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations